Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Expert Review of Anticancer Therapy
|
October 18, 2012
Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients
Lucia Del Mastro, Matteo Lambertini, Claudia Bighin, et al.
Radiation Oncology (London, England)
|
November 25, 2010
A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects
Marina Guenzi, Stefano Vagge, Ngwa Che Azinwi, et al.
ESMO Open
|
December 19, 2018
Management of young women with early breast cancer
Francesca Poggio, Matteo Lambertini, Claudia Bighin, et al.
Aesthetic Plastic Surgery
|
May 11, 2011
Preliminary experience using oncoplastic techniques of reduction mammaplasty and intraoperative radiotherapy: report of 2 cases
Simonetta Franchelli, Paolo Meszaros, Marina Guenzi, et al.
Anticancer Research
|
December 1, 2010
Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university
Renzo Corvò, Francesco Ricchetti, Daniela Doino, et al.
Clinical Medicine Insights. Reproductive Health
|
August 9, 2019
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
Francesca Poggio, Matteo Lambertini, Claudia Bighin, et al.
Anticancer Research
|
July 2, 2014
Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer
Alessia Levaggi, Andrea De Maria, Beatrice Dozin, et al.
Cancer Treatment Reviews
|
December 24, 2013
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials
Lucia Del Mastro, Marcello Ceppi, Francesca Poggio, et al.
The Breast Journal
|
April 2, 2019
Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity
Rossella Martinello, Paolo Becco, Patrizia Vici, et al.
Breast Cancer Research and Treatment
|
September 25, 2016
Treatment with aromatase inhibitors and markers of cardiovascular disease
Eva Blondeaux, Debora Musio, Paolo Bruzzi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Expert Review of Anticancer Therapy
|
October 18, 2012
Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients
Lucia Del Mastro, Matteo Lambertini, Claudia Bighin, et al.
Radiation Oncology (London, England)
|
November 25, 2010
A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects
Marina Guenzi, Stefano Vagge, Ngwa Che Azinwi, et al.
ESMO Open
|
December 19, 2018
Management of young women with early breast cancer
Francesca Poggio, Matteo Lambertini, Claudia Bighin, et al.
Aesthetic Plastic Surgery
|
May 11, 2011
Preliminary experience using oncoplastic techniques of reduction mammaplasty and intraoperative radiotherapy: report of 2 cases
Simonetta Franchelli, Paolo Meszaros, Marina Guenzi, et al.
Anticancer Research
|
December 1, 2010
Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university
Renzo Corvò, Francesco Ricchetti, Daniela Doino, et al.
Clinical Medicine Insights. Reproductive Health
|
August 9, 2019
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
Francesca Poggio, Matteo Lambertini, Claudia Bighin, et al.
Anticancer Research
|
July 2, 2014
Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer
Alessia Levaggi, Andrea De Maria, Beatrice Dozin, et al.
Cancer Treatment Reviews
|
December 24, 2013
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials
Lucia Del Mastro, Marcello Ceppi, Francesca Poggio, et al.
The Breast Journal
|
April 2, 2019
Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity
Rossella Martinello, Paolo Becco, Patrizia Vici, et al.
Breast Cancer Research and Treatment
|
September 25, 2016
Treatment with aromatase inhibitors and markers of cardiovascular disease
Eva Blondeaux, Debora Musio, Paolo Bruzzi, et al.
Page
of 2